| Original language | English (US) |
|---|---|
| Pages (from-to) | 131-132 |
| Number of pages | 2 |
| Journal | Journal of Laboratory and Clinical Medicine |
| Volume | 139 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2002 |
| Externally published | Yes |
Fingerprint
Apolipoproteins A
Lipoprotein(a)
Particle Size
Cardiovascular Diseases
ASJC Scopus subject areas
- Medicine(all)
- Pathology and Forensic Medicine
Cite this
Lipoprotein (a) : Where does the atherogenicity reside? / Berglund, Lars.
In: Journal of Laboratory and Clinical Medicine, Vol. 139, No. 3, 2002, p. 131-132.Research output: Contribution to journal › Article
Berglund, L 2002, 'Lipoprotein (a): Where does the atherogenicity reside?', Journal of Laboratory and Clinical Medicine, vol. 139, no. 3, pp. 131-132. https://doi.org/10.1067/mlc.2002.121769
@article{f7dc47dc82ca4b678aa0f2d7e0030e81,
title = "Lipoprotein (a): Where does the atherogenicity reside?",
author = "Lars Berglund",
year = "2002",
doi = "10.1067/mlc.2002.121769",
language = "English (US)",
volume = "139",
pages = "131--132",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "3",
}
TY - JOUR
T1 - Lipoprotein (a)
T2 - Where does the atherogenicity reside?
AU - Berglund, Lars
PY - 2002
Y1 - 2002
UR - http://www.scopus.com/inward/record.url?scp=0036010026&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036010026&partnerID=8YFLogxK
U2 - 10.1067/mlc.2002.121769
DO - 10.1067/mlc.2002.121769
M3 - Article
VL - 139
SP - 131
EP - 132
JO - Translational Research
JF - Translational Research
SN - 1931-5244
IS - 3
ER -